Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cellumed Co Ltd (049180) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7388
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterilize them with gamma rays to ensure sterilization; hard tissue comprising bone shaft, bone chip, and wedge and block; soft tissue consisting cartilage and ligament and tendon; skin tissue; and spinal spacers. It provides biologics comprising bone sponge, bone powder, and DBM gel; and bio-similar products including bone morphogenetic protein 2 (BMP2) reagent and BMP2 DBM gel. Cellumed offers medical devices such as spinal fixation system products, which includes EOS pedicle screw system and PALLA MIS; joint replacement products such as B-P total knee, hip, and shoulder replacement surgery products; and navigation systems for use in artificial knee joint surgery with correct positioning. The company operates its offices in Seoul, Daegu, Daejeon, Gwangju, Jeollabuk-Do and Busan, South Korea. Cellumed is headquartered in Seoul, South Korea.

Cellumed Co Ltd (049180) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cellumed Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellumed Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cellumed Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellumed Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cellumed Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cellumed Co Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Cellumed to Raise USD0.8 Million in Public Offering of Shares 10
Cellumed Raises USD1.6 Million in Private Placement of Shares 11
Cellumed Raises USD0.8 Million in Public Offering of Shares 12
Debt Offering 13
Cellumed Raises USD9 Million in Public Offering of Bonds 13
Cellumed Raises USD0.8 Million in Private Placement of Convertible Bonds 14
Cellumed Raises USD5.5 Million in Unregistered and Unsecured Private Convertible Bonds Due 2020 15
Cellumed to Raise USD2 Million in Public Offering of 6% Bonds Due 2019 16
Cellumed to Raise USD2.7 Million in Public Offering of Bonds 17
Cellumed Raises USD1.74 Million in Unregistered and Unsecured Private Convertible Bonds Due 2018 18
Cellumed Co Ltd – Key Competitors 19
Cellumed Co Ltd – Key Employees 20
Cellumed Co Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Cellumed Co Ltd, Medical Equipment, Key Facts, 2017 2
Cellumed Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cellumed Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellumed Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cellumed Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellumed Co Ltd, Deals By Market, 2012 to YTD 2018 8
Cellumed Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cellumed to Raise USD0.8 Million in Public Offering of Shares 10
Cellumed Raises USD1.6 Million in Private Placement of Shares 11
Cellumed Raises USD0.8 Million in Public Offering of Shares 12
Cellumed Raises USD9 Million in Public Offering of Bonds 13
Cellumed Raises USD0.8 Million in Private Placement of Convertible Bonds 14
Cellumed Raises USD5.5 Million in Unregistered and Unsecured Private Convertible Bonds Due 2020 15
Cellumed to Raise USD2 Million in Public Offering of 6% Bonds Due 2019 16
Cellumed to Raise USD2.7 Million in Public Offering of Bonds 17
Cellumed Raises USD1.74 Million in Unregistered and Unsecured Private Convertible Bonds Due 2018 18
Cellumed Co Ltd, Key Competitors 19
Cellumed Co Ltd, Key Employees 20
Cellumed Co Ltd, Other Locations 21

List of Figures
Cellumed Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cellumed Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cellumed Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cellumed Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cellumed Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cellumed Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cellumed Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cellumed Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Subaru Corp (7270):企業の財務・戦略的SWOT分析
    Subaru Corp (7270) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Guerbet SA (GBT)-医療機器分野:企業M&A・提携分析
    Summary Guerbet SA (Guerbet) is a specialty pharmaceutical company which manufactures and markets medical imaging contrast agents destined for diagnostic purposes. The company provides a wide range of contrast agents for X-ray examinations and Magnetic Resonance Imaging (MRI). Guerbet also provides …
  • Polarcus Ltd (PLCS):企業の財務・戦略的SWOT分析
    Summary Polarcus Ltd (Polarcus) is a marine geophysical company that provides towed streamer data acquisition and imaging services. The company provides marine acquisition services such as vessel specifications, increasing efficiency, managing emissions to air, managing emissions to sea, polar code …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Advanced Energy Industries Inc (AEIS):電力:M&Aディール及び事業提携情報
    Summary Advanced Energy Industries, Inc. (Advanced Energy) is a provider of power conversion, measurement and control solutions. The company designs, manufactures, sells, and supports power conversion products and solutions. These products are used in various applications ranging from manufacturing …
  • Haci Omer Sabanci Holding A.S. (SAHOL):企業の財務・戦略的SWOT分析
    Haci Omer Sabanci Holding A.S. (SAHOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Dermapharm AG-製薬・医療分野:企業M&A・提携分析
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparation …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Ingenico SA (ING):企業の財務・戦略的SWOT分析
    Ingenico SA (ING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • Rapiscan Systems, Inc.:戦略・SWOT・企業財務分析
    Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rapiscan Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • New York Independent System Operator Inc:企業の戦略的SWOT分析
    New York Independent System Operator Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Nielsen Holdings PLC:企業のM&A・事業提携・投資動向
    Nielsen Holdings PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nielsen Holdings PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • The National Commercial Bank:企業の戦略・SWOT・財務分析
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abbott Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Lookers Plc:企業のM&A・事業提携・投資動向
    Lookers Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lookers Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Coffee Republic Trading Ltd:企業の戦略・SWOT・財務情報
    Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report Summary Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • GCL System Integration Technology Co Ltd (002506):電力:M&Aディール及び事業提携情報
    Summary GCL System Integration Technology Co Ltd (GCL System Integration), formerly Shanghai Chaori Solar Energy Science & Technology Co Ltd, a subsidiary of Golden Concord Holdings Ltd, is a renewable energy company that offers clean and sustainable power production services. The company's products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆